| __timestamp | Bio-Techne Corporation | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 60716000 | 5699000000 |
| Thursday, January 1, 2015 | 119401000 | 5001000000 |
| Friday, January 1, 2016 | 140879000 | 5002000000 |
| Sunday, January 1, 2017 | 199243000 | 4849000000 |
| Monday, January 1, 2018 | 240636000 | 4551000000 |
| Tuesday, January 1, 2019 | 264359000 | 4871000000 |
| Wednesday, January 1, 2020 | 260583000 | 7661000000 |
| Friday, January 1, 2021 | 324951000 | 7690000000 |
| Saturday, January 1, 2022 | 372766000 | 7814000000 |
| Sunday, January 1, 2023 | 378378000 | 7772000000 |
| Monday, January 1, 2024 | 396826000 | 8414000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical and biotechnology sectors, understanding operational efficiency is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Bristol-Myers Squibb Company and Bio-Techne Corporation from 2014 to 2023. Over this period, Bristol-Myers Squibb consistently reported higher SG&A expenses, peaking in 2022 with a staggering 7.8 billion dollars. In contrast, Bio-Techne's expenses grew steadily, reaching approximately 397 million dollars in 2023, marking a 554% increase from 2014.
This comparison highlights the contrasting strategies of a pharmaceutical giant and a growing biotech firm, offering valuable insights into their operational priorities.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company or Zoetis Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Bristol-Myers Squibb Company vs Neurocrine Biosciences, Inc.
Bristol-Myers Squibb Company and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Agios Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
SG&A Efficiency Analysis: Comparing Biogen Inc. and Bio-Techne Corporation
Operational Costs Compared: SG&A Analysis of Intra-Cellular Therapies, Inc. and Bio-Techne Corporation
Bio-Techne Corporation and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Bio-Techne Corporation and Grifols, S.A.
Cost Management Insights: SG&A Expenses for Bio-Techne Corporation and Vericel Corporation